Clinical significance of HER-2 protein expression in Human Gastric Carcinoma
Liu Du-li
Abstract
Liu Du-li
Abstract
Objective To investigate the correlation between HER-2 protein expression and clinicopathological factors of gastric carcinoma.Methods HER-2 protein expression was detected by immunohistochemistry(Envision) in 70 gastric carcinoma specimens,and the corresponding clinical and pathological characteristics were also analyzed.Results The positive rate of HER-2 protein expression was 27.1%(19/70).HER-2 over-expression rate was 15.7%(11/70).HER-2 protein expression was associated with the tumor differentiation,invasion depth,lymph note metastasis and TNM stage(P 0.05),but not with sex,age,tumor site and tumor size(P 0.05).Conclusion HER-2 expression may participate in the development,invasion and metastasis of gastric carcinoma.Detecting the HER-2 status is a prerequisite of? trastuzumab monoclonal antibody(Herceptin) therapy for gastric carcinoma,and can assess the malignant biological behaviors and prognosis of gastric carcinoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the correlation between HER-2 protein expression and clinicopathological factors of gastric carcinoma.Methods HER-2 protein expression was detected by immunohistochemistry(Envision) in 70 gastric carcinoma specimens,and the corresponding clinical and pathological characteristics were also analyzed.Results The positive rate of HER-2 protein expression was 27.1%(19/70).HER-2 over-expression rate was 15.7%(11/70).HER-2 protein expression was associated with the tumor differentiation,invasion depth,lymph note metastasis and TNM stage(P 0.05),but not with sex,age,tumor site and tumor size(P 0.05).Conclusion HER-2 expression may participate in the development,invasion and metastasis of gastric carcinoma.Detecting the HER-2 status is a prerequisite of? trastuzumab monoclonal antibody(Herceptin) therapy for gastric carcinoma,and can assess the malignant biological behaviors and prognosis of gastric carcinoma.
Key concepts: Medicine, Immunohistochemistry, Gastric carcinoma, Trastuzumab, Pathological, Stage (stratigraphy), Metastasis, Monoclonal antibody